BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20574716)

  • 21. Reversible Leukoencephalopathy in a Man with Childhood-onset Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome.
    Hoshino Y; Kodaira M; Matsuno A; Kaneko T; Fukuyama T; Takano K; Yazaki M; Sekijima Y
    Intern Med; 2022 Feb; 61(4):553-557. PubMed ID: 34433721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The human and mouse SLC25A29 mitochondrial transporters rescue the deficient ornithine metabolism in fibroblasts of patients with the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome.
    Camacho JA; Rioseco-Camacho N
    Pediatr Res; 2009 Jul; 66(1):35-41. PubMed ID: 19287344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seven novel mutations in the ORNT1 gene (SLC25A15) in patients with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome.
    Salvi S; Dionisi-Vici C; Bertini E; Verardo M; Santorelli FM
    Hum Mutat; 2001 Nov; 18(5):460. PubMed ID: 11668643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel R275X mutation of the SLC25A15 gene in a Japanese patient with the HHH syndrome.
    Torisu H; Kira R; Kanazawa N; Takemoto M; Sanefuji M; Sakai Y; Tsujino S; Hara T
    Brain Dev; 2006 Jun; 28(5):332-5. PubMed ID: 16376511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful liver transplantation in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: Case report.
    De Bruyne P; Verloo P; Van Hove JLK; de Hemptinne B; Vande Velde S; Van Winckel M; Van Biervliet S; De Bruyne R
    Pediatr Transplant; 2021 Sep; 25(6):e13943. PubMed ID: 33314525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperornithinemia, Hyperammonemia, and Homocitrullinuria Syndrome Causing Severe Neonatal Hyperammonemia.
    Wild KT; Ganetzky RD; Yudkoff M; Ierardi-Curto L
    JIMD Rep; 2019; 44():103-107. PubMed ID: 30187369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late onset hyperornithinemia-hyperammonemia-homocitrullinuria syndrome - how web searching by the family solved unexplained unconsciousness: a case report.
    Silfverberg T; Sahlander F; Enlund M; Oscarson M; Hårdstedt M
    J Med Case Rep; 2018 Sep; 12(1):274. PubMed ID: 30243302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corticospinal tract damage in HHH syndrome: a metabolic cause of hereditary spastic paraplegia.
    Olivieri G; Pro S; Diodato D; Di Capua M; Longo D; Martinelli D; Bertini E; Dionisi-Vici C
    Orphanet J Rare Dis; 2019 Aug; 14(1):208. PubMed ID: 31443672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, biochemical, and genotypical characteristics in urea cycle mitochondrial transporter disorders.
    Bilgin H; Bilge S; Binici M; Tekes S
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):1873-1880. PubMed ID: 38497870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of dietary treatment and amino acid supplementation in organic acidurias and urea-cycle disorders: On the basis of information from a European multicenter registry.
    Molema F; Gleich F; Burgard P; van der Ploeg AT; Summar ML; Chapman KA; Barić I; Lund AM; Kölker S; Williams M;
    J Inherit Metab Dis; 2019 Nov; 42(6):1162-1175. PubMed ID: 30734935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter.
    Camacho JA; Obie C; Biery B; Goodman BK; Hu CA; Almashanu S; Steel G; Casey R; Lambert M; Mitchell GA; Valle D
    Nat Genet; 1999 Jun; 22(2):151-8. PubMed ID: 10369256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular genetic studies of mitochondrial ornithine transporter deficiency (HHH syndrome)].
    Tsujino S; Miyamoto T; Kanazawa N
    Nihon Rinsho; 2001 Nov; 59(11):2278-84. PubMed ID: 11712419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput tandem mass spectrometry multiplex analysis for newborn urinary screening of creatine synthesis and transport disorders, Triple H syndrome and OTC deficiency.
    Auray-Blais C; Maranda B; Lavoie P
    Clin Chim Acta; 2014 Sep; 436():249-55. PubMed ID: 24909877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of Japanese patients with HHH syndrome by molecular genetic analysis: a common mutation, R179X.
    Miyamoto T; Kanazawa N; Kato S; Kawakami M; Inoue Y; Kuhara T; Inoue T; Takeshita K; Tsujino S
    J Hum Genet; 2001; 46(5):260-2. PubMed ID: 11355015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision.
    Häberle J; Burlina A; Chakrapani A; Dixon M; Karall D; Lindner M; Mandel H; Martinelli D; Pintos-Morell G; Santer R; Skouma A; Servais A; Tal G; Rubio V; Huemer M; Dionisi-Vici C
    J Inherit Metab Dis; 2019 Nov; 42(6):1192-1230. PubMed ID: 30982989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ornithine and Homocitrulline Impair Mitochondrial Function, Decrease Antioxidant Defenses and Induce Cell Death in Menadione-Stressed Rat Cortical Astrocytes: Potential Mechanisms of Neurological Dysfunction in HHH Syndrome.
    Zanatta Â; Rodrigues MD; Amaral AU; Souza DG; Quincozes-Santos A; Wajner M
    Neurochem Res; 2016 Sep; 41(9):2190-8. PubMed ID: 27161368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ornithine In Vivo Administration Disrupts Redox Homeostasis and Decreases Synaptic Na(+), K (+)-ATPase Activity in Cerebellum of Adolescent Rats: Implications for the Pathogenesis of Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome.
    Zanatta Â; Viegas CM; Hickmann FH; de Oliveira Monteiro W; Sitta A; de Moura Coelho D; Vargas CR; Leipnitz G; Wajner M
    Cell Mol Neurobiol; 2015 Aug; 35(6):797-806. PubMed ID: 25772141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three novel mutations (G27E, insAAC, R179X) in the ORNT1 gene of Japanese patients with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome.
    Tsujino S; Kanazawa N; Ohashi T; Eto Y; Saito T; Kira J; Yamada T
    Ann Neurol; 2000 May; 47(5):625-31. PubMed ID: 10805333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal urinary excretion of polyamines in HHH syndrome (hyperornithinemia associated with hyperammonemia and homocitrullinuria).
    Shimizu H; Maekawa K; Eto Y
    Brain Dev; 1990; 12(5):533-5. PubMed ID: 2288388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mutation, P126R, in a Japanese patient with HHH syndrome.
    Miyamoto T; Kanazawa N; Hayakawa C; Tsujino S
    Pediatr Neurol; 2002 Jan; 26(1):65-7. PubMed ID: 11814739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.